Secretin Receptor antibody orb11357 from Biorbyt | Biocompare.com

Supplier Images

Secretin Receptor antibody

Immunohistochemical staining of paraffin embedded human stomach tissue

Be the first to write a review!

Citations:

Supplier Page from
Biorbyt for
Secretin Receptor antibody

The Secretin Receptor antibody from Biorbyt is a Rabbit Polyclonal antibody to Secretin Receptor. This antibody recognizes Mouse antigen. The Secretin Receptor antibody has been validated for the following applications: EIA, Immunoassay, ELISA, Immunofluorescence, Immunohistochemistry, Immunohistochemistry - fixed, Immunohistochemistry - frozen, and Western Blot.

Description

Secretin Receptor antibody

Product Specs
ItemSecretin Receptor antibody
CompanyBiorbyt
Price Pricing Info Supplier Page
Catalog Numberorb11357
ReactivityMouse
TargetSecretin Receptor
Quantity50 µl, 100 µl, 200 µl
ApplicationsELISA, IF, IHC-Fr, IHC-P, WB
Conjugate/TagUnconjugated
ClonalityPolyclonal
FormatLiquid
ImmunogenKLH conjugated synthetic peptide derived from human Secretin receptor (188-280/440 aa)
Molecular Weight46 kDa
IsotypeIgG
HostRabbit
Concentration1mg/ml
NCBI Full Gene Namesecretin receptor
NCBI Gene AliasesSR
StorageShipped at 4°C. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles

Specifications/Features

Application Dilutions: WB=1:500-2000, IHC-P=1:100-500, IHC-F=1:100-500, IF=1:100-500, ELISA=1:5000-10000

Add to Compare List

Biorbyt

Biorbyt

7, Signet Court

Swann Road

Cambridge, Cambridgeshire CB5 8LA

United Kingdom

Phone: +44(0)1223 815 212
+44(0)1223 280 240 (fax)
+44(0)1223 280 240

Email: info@biorbyt.com
support@biorbyt.com
accounts@biorbyt.com

Company Profile

Website: https://www.biorbyt.com/

(1) Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2^-/- mice by diminishing senescence of cholangiocytesLaboratory investigation; a journal of technical methods and pathologyNovember 1, 2018Zhou T, Wu N, Meng F, Venter J, Giang TK, Francis H, Kyritsi K, Wu C, Franchitto A, Alvaro D, et al.

(2) Massive osteolysis of the skull and its therapeutic implications: a case reportJournal of neurology, neurosurgery, and psychiatryFebruary 1, 1989Bouwsma C, Go G, Panders A, Schoots C, Vencken L.

(3) Long term treatment of Graves'' hyperthyroidism with sodium ipodateThe Journal of clinical endocrinology and metabolismOctober 1, 1985Shen DC, Wu SY, Chopra IJ, Huang HW, Shian LR, Bian TY, Jeng CY, Solomon DH.

Be the First to Write a Review!